Eversense
“10-K Item 1A: 'We are dependent on one product, Eversense. Our success depends on our ability to continue to develop, commercialize and gain market acceptance for our products.'”
Updated
The most significant concentration Senseonics Holdings discloses is Eversense, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Senseonics Holdings’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
“10-K Item 1A: 'We are dependent on one product, Eversense. Our success depends on our ability to continue to develop, commercialize and gain market acceptance for our products.'”
“10-K Item 1A: 'We do not have any manufacturing facilities or direct manufacturing personnel. ... We currently rely, and expect to continue to rely, on third parties for the manufacture of Eversense'”
Senseonics' concentration risk is unusually compounded, with two high-share exposures reinforcing each other around a single product. The company discloses that it is dependent on one product, Eversense, and that its success depends on its ability to continue to develop, commercialize and gain market acceptance for its products — a high-share exposure with a mixed character, reflecting both a structural feature of being a single-product company and an execution-dependent commercial risk. Layered on top, Senseonics discloses a high-share, dependency-type exposure on the manufacturing side: it does not operate any manufacturing facilities or employ direct manufacturing personnel, and instead relies, and expects to continue to rely, on third parties for the manufacture of Eversense. Because the company has no alternate product line to fall back on and no in-house manufacturing capability, these two exposures are not independent of one another — a disruption at a third-party manufacturer would directly threaten the availability of the one product the entire business depends on, and any slowdown in Eversense's commercial adoption has no offsetting revenue source elsewhere in the business. This combination of single-product dependence and fully outsourced manufacturing of that same product makes Senseonics' concentration profile tightly linked rather than diversified across multiple exposures.
For the engine’s reasoning on SENS’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| AORT | Artivion, Inc. | 4 | 4 | 0 | 8 |
| SENS● | Senseonics Holdings, Inc. | 2 | 0 | 0 | 2 |
| ATEC | Alphatec Holdings, Inc. | 1 | 1 | 0 | 2 |
| ABT | Abbott Laboratories | 1 | 0 | 0 | 1 |
| AHCO | AdaptHealth Corp. | 0 | 0 | 0 | 0 |
| AXGN | AxoGen, Inc. | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.